跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
ROCURONIUM BROMIDE INJECTION
Authorized
STANDARD
ROCURONIUM BROMIDE INJECTION
hikma canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e2f27f97cddefaa6
Company
hikma canada limited
Type
Standard
Approval Details
Approval Id
e2f27f97cddefaa6
Drug Approval Canada Name
ROCURONIUM BROMIDE INJECTION
Product Name
ROCURONIUM BROMIDE INJECTION
Status
Marketed
Status Date
2023-09-29
Original Market Date
2023-09-29
Din
02517744
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
12:20.20
Atc Original
M03AC09 ROCURONIUM BROMIDE
Atc Name
m 03 ac 09
Aig Number
0126317001
Company Name
hikma canada limited
Company Address
5995 Avebury Road, Suite 804, Mississauga, Ontario, Canada, L5R 3P9
Active Ingredients
ROCURONIUM BROMIDE
10 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e2f27f97cddefaa6
Type
Standard
Back to Health Canada Approvals
ROCURONIUM BROMIDE INJECTION - Health Canada Drug Approval Details